David Klonoff, MD
Enriched profileMedical Director, Dorothy L. and James E. Frank Diabetes Research Institute; Clinical Professor of Medicine, UCSF · Mills-Peninsula Medical Center (Sutter Health)
David Klonoff is Medical Director, Dorothy L. and James E. Frank Diabetes Research Institute; Clinical Professor of Medicine, UCSF at Mills-Peninsula Medical Center (Sutter Health). OpenAlex indexes 423 publications with 14,043 citations (h-index 60); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David C. Klonoff, MD, is Medical Director, Dorothy L. and James E. Frank Diabetes Research Institute at Mills-Peninsula Medical Center (Sutter Health), San Mateo/Burlingame, CA. The public record shows 423 publications with 14,043 citations (h-index 60), centered on Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Treatment and Management. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 9 companies, 1 NIH-funded awards (1999–1999).
- Most recent indexed publication: 2026 · Nature biomedical engineering
- Top research focus: Diabetes Management and Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 135 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 195.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Sponsor: Medtronic MiniMed, Inc.
- Green Digital Diabetes Waste Project
Sponsor: Florida State University
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Embecta Corp.Program year20252 payments
- Medtronic, Inc.Program year20254 payments
- Novo Nordisk IncProgram year20252 payments
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%GLP-1 receptor agonist69.4%Ozempic52%Trulicity48%Part D<11 patientsDPP-4 inhibitor30.6%Tradjenta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1999–1999 per NIH RePORTER. The latest:
- NONINVASIVE GLUCOSE MONITOR CLINICAL PROTOTYPE PERFORMANCE VALIDATION
University of California San Francisco
FY1999M01RR000079
Congress activity
Updated 27 Aug 2026
21 congress contributions (2018–2025) across ADA per OpenAlex. The most recent:
- 1058-P: The Need for Clear Ownership Laws for Medical Data Generated by Wearable Diabetes Devices
ADA Scientific Sessions
ADA2025Presenting authorPoster - 1098-P: Tracking Treatment Outcomes Using the Semaglutide Patient Support Solution App
ADA Scientific Sessions
ADA2025Co-authorPoster - 1972-LB: Glucagon-Like Peptide 1 Receptor Agonists and NAION—A Systematic Review and Meta-analysis
ADA Scientific Sessions
ADA2025Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Glucose Dysregulation in Hantavirus Infection: A Signal Worth Watching With Continuous Glucose Monitoring.
Journal of diabetes science and technology
Letter2026 - Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.
Stroke research and treatment
Article2026 - Beyond the Mean: A Machine Learning-Based Trend Analysis of CGM Metrics for Improved HbA(1C) Estimation in Type 2 Diabetes.
Journal of diabetes science and technology
Article2026 - Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.
Journal of diabetes science and technology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Continuous Glucose Monitoring723 citations2005
- 02
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-klonoff-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/david-klonoff-61040761
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/David-Klonoff-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- MD
UCSF School of Medicine (elected to Alpha Omega Alpha in junior year)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗ - BA
UC Berkeley (elected to Phi Beta Kappa in junior year)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗ - FACP - Fellow
American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗ - Postgraduate training: 2 years internal medicine residency at UCLA Hospital
3 years at UCSF Hospitals (endocrinology fellowship)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Founding Editor-in-Chief
Journal of Diabetes Science and Technology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →professional.diabetes.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- Clinical Professor of Medicine
University of California, San Francisco (UCSF)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- Co-host
"Diabetes Technology Report" podcast (with David Kerr, Sutter Health), covers glucose monitoring, insulin delivery, digital health, cybersecurity, AI in diabetes
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗ - Speaker
"Cybersecurity for Connected Medical Devices", UCSF Events Calendar presentation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →calendar.ucsf.edu ↗ - Advisory Board member
Know Labs (medical device company), announced via press release
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →businesswire.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH